104 related articles for article (PubMed ID: 22836860)
1. Does prophylactic administration of somatostatin decrease the rates of complications after pancreatic resection?: A clinical and electron microscopy study.
Katsourakis A; Zezos P; Noussios G; Kouklakis G; Chatzitheoklitos E; Simopoulos K; Pitiakoudis M
Pancreas; 2013 Jan; 42(1):37-41. PubMed ID: 22836860
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection.
Ramos-De la Medina A; Sarr MG
J Hepatobiliary Pancreat Surg; 2006; 13(3):190-3. PubMed ID: 16708293
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled study of the efficacy of preoperative somatostatin administration in the prevention of postoperative complications following pancreaticoduodenectomy.
Wang W; Tian B; Babu SR; Zhang Y; Yang M
Hepatogastroenterology; 2013 May; 60(123):400-5. PubMed ID: 23178468
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic resection: drain or no drain?
Adham M; Chopin-Laly X; Lepilliez V; Gincul R; Valette PJ; Ponchon T
Surgery; 2013 Nov; 154(5):1069-77. PubMed ID: 23876363
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit?
Anderson RJ; Dunki-Jacobs E; Callender GG; Burnett N; Scoggins CR; McMasters KM; Martin RC
Surgery; 2013 Oct; 154(4):755-60; discussion 760. PubMed ID: 24074412
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula.
Weber SM; Cho CS; Merchant N; Pinchot S; Rettammel R; Nakeeb A; Bentrem D; Parikh A; Mazo AE; Martin RC; Scoggins CR; Ahmad SA; Kim HJ; Hamilton N; Hawkins W; Max Schmidt C; Kooby DA
Ann Surg Oncol; 2009 Oct; 16(10):2825-33. PubMed ID: 19609621
[TBL] [Abstract][Full Text] [Related]
7. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL
Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374
[TBL] [Abstract][Full Text] [Related]
8. Is age a risk factor for major pancreatic surgery? An analysis of 300 resections.
Bottger TC; Engelmann R; Junginger T
Hepatogastroenterology; 1999; 46(28):2589-98. PubMed ID: 10522047
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of postoperative pancreatic complications following duodenopancreatectomy using somatostatin].
Klempa I; Schwedes U; Usadel KH
Chirurg; 1979 Jul; 50(7):427-31. PubMed ID: 477469
[TBL] [Abstract][Full Text] [Related]
10. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial.
Sarr MG;
J Am Coll Surg; 2003 Apr; 196(4):556-64; discussion 564-5; author reply 565. PubMed ID: 12691930
[TBL] [Abstract][Full Text] [Related]
11. The influence of somatostatin on postoperative outcome after elective pancreatic surgery.
Van Hee R; De Laet I; Salgado R; Ysebaert D
Acta Chir Belg; 1998; 98(2):62-5. PubMed ID: 9615159
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic fistula after pancreatic head resection.
Büchler MW; Friess H; Wagner M; Kulli C; Wagener V; Z'Graggen K
Br J Surg; 2000 Jul; 87(7):883-9. PubMed ID: 10931023
[TBL] [Abstract][Full Text] [Related]
13. [Morbidity and mortality in pancreatic resection].
Dominguez-Comesaña E; Gonzalez-Rodriguez FJ; Ulla-Rocha JL; Lede-Fernandez A; Portela-Serra JL; Piñon-Cimadevila MÁ
Cir Esp; 2013 Dec; 91(10):651-8. PubMed ID: 23541704
[TBL] [Abstract][Full Text] [Related]
14. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial.
Okabayashi T; Nishimori I; Yamashita K; Sugimoto T; Maeda H; Yatabe T; Kohsaki T; Kobayashi M; Hanazaki K
Arch Surg; 2009 Oct; 144(10):933-7. PubMed ID: 19841361
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
[TBL] [Abstract][Full Text] [Related]
16. [Somatostatin prophylaxis following cephalic duodenopancreatectomy].
Beguiristain A; Espí A; Balen E; Pardo F; Hernández Lizoaín JL; Alvarez Cienfuegos J
Rev Esp Enferm Dig; 1995 Mar; 87(3):221-4. PubMed ID: 7742052
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of pancreatic fistulas with somatostatin].
Berthet B; Delaitre P; Berdah S; Assadourian R
J Chir (Paris); 1995 May; 132(5):225-8. PubMed ID: 7642727
[TBL] [Abstract][Full Text] [Related]
18. In vivo octreotide administration acutely reduces exocrine granule size in the human pancreas.
Falconi M; Caldiron E; Zancanaro C; Benati D; Talamini G; Bassi C; Pederzoli P
Pancreatology; 2001; 1(1):30-5. PubMed ID: 12120265
[TBL] [Abstract][Full Text] [Related]
19. [Prevention and management of postoperative complications in pancreatic surgery].
Sülberg D; Chromik AM; Köster O; Uhl W
Zentralbl Chir; 2010 Apr; 135(2):129-38. PubMed ID: 20379943
[TBL] [Abstract][Full Text] [Related]
20. [Pancreatic fistula after left pancreatectomy. Frequency and severity].
Bonnichon P; Tong JZ; Ortega D; Louvel A; Grateau F; Icard P; Chapuis Y
J Chir (Paris); 1988 May; 125(5):321-6. PubMed ID: 2898481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
